Stocktake of PBS medicines available for endometriosis and related conditions, and comparison of current Australian pharmacological treatment guidelines (2022) Report

Page last updated: 28 March 2024

A ‘Stocktake of medicines listed on the Phamaceutical Benefits Scheme (PBS) for the treatment of endometriosis and related conditions and comparison of current Australain pharmacological treatment guidelines’ report was considered by the Pharmaceutical Benefits Advisory Committee (PBAC) in December 2022. The purpose of the stocktake was to identify potential gaps between PBS-funded medicines and medicines available to patients privately (at full cost). 

The Stocktake Report and a Consumer Summary are now available.